메뉴 건너뛰기




Volumn 384, Issue 9942, 2014, Pages 474-475

Nicotinamide in Friedreich's ataxia: Useful or not?

Author keywords

[No Author keywords available]

Indexed keywords

FRATAXIN; HISTONE DEACETYLASE INHIBITOR; NICOTINAMIDE; HISTONE DEACETYLASE; MESSENGER RNA;

EID: 84906318602     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60573-0     Document Type: Note
Times cited : (7)

References (8)
  • 1
    • 62549117369 scopus 로고    scopus 로고
    • Friedreich ataxia: The clinical picture
    • M Pandolfo Friedreich ataxia: the clinical picture J Neurol 256 suppl 1 2009 3 8
    • (2009) J Neurol , vol.256 , Issue.1 , pp. 3-8
    • Pandolfo, M.1
  • 2
    • 84880354651 scopus 로고    scopus 로고
    • Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia
    • JM Gottesfeld, JR Rusche, M Pandolfo Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia J Neurochem 126 suppl 1 2013 147 154
    • (2013) J Neurochem , vol.126 , Issue.1 , pp. 147-154
    • Gottesfeld, J.M.1    Rusche, J.R.2    Pandolfo, M.3
  • 3
    • 84878912414 scopus 로고    scopus 로고
    • Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3
    • PK Chan, R Torres, C Yandim et al. Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3 Hum Mol Genet 22 2013 2662 2675
    • (2013) Hum Mol Genet , vol.22 , pp. 2662-2675
    • Chan, P.K.1    Torres, R.2    Yandim, C.3
  • 4
    • 84906326678 scopus 로고    scopus 로고
    • Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: An exploratory, open-label, dose-escalation study
    • published online May 1
    • V Libri, C Yandim, S Athanasopoulos et al. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study Lancet 2014 published online May 1. http://dx.doi.org/10.1016/S0140-6736(14)60382-2
    • (2014) Lancet
    • Libri, V.1    Yandim, C.2    Athanasopoulos, S.3
  • 5
    • 84906304852 scopus 로고    scopus 로고
    • US National Library of Medicine (accessed March 17, 2014)
    • US National Library of Medicine MedlinePlus - niacin and niacinamide (vitamin B3) http://www.nlm.nih.gov/medlineplus/druginfo/natural/924.html (accessed March 17, 2014).
    • MedlinePlus - Niacin and Niacinamide (Vitamin B3)
  • 6
    • 77957244407 scopus 로고    scopus 로고
    • A rapid, noninvasive immunoassay for frataxin: Utility in assessment of Friedreich ataxia
    • EC Deutsch, AB Santani, SL Perlman et al. A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia Mol Genet Metab 101 2010 238 245
    • (2010) Mol Genet Metab , vol.101 , pp. 238-245
    • Deutsch, E.C.1    Santani, A.B.2    Perlman, S.L.3
  • 7
    • 84864024011 scopus 로고    scopus 로고
    • A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial
    • DR Lynch, SM Willi, RB Wilson et al. A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial Mov Disord 27 2012 1026 1033
    • (2012) Mov Disord , vol.27 , pp. 1026-1033
    • Lynch, D.R.1    Willi, S.M.2    Wilson, R.B.3
  • 8
    • 84865662814 scopus 로고    scopus 로고
    • Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia
    • E Soragni, C Xu, HL Plasterer, V Jacques, JR Rusche, JM Gottesfeld Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia J Child Neurol 27 2012 1164 1173
    • (2012) J Child Neurol , vol.27 , pp. 1164-1173
    • Soragni, E.1    Xu, C.2    Plasterer, H.L.3    Jacques, V.4    Rusche, J.R.5    Gottesfeld, J.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.